CALA Calithera Biosciences Inc

Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

$2.69
As of 03/04/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
10/02/2014
70,558,711
1,258,838
$198,269,978
0.00%
SEC Edgar Online
10-Q
10-K
13089P101
US13089P1012
BQXZNP9

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
1.62
0.00
-72.84%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy